@ARTICLE{
author={Ramalingam Suresh S,Zaric Bojan,Ceric Timur,...,Samarzija Miroslav,...,Vukovic Vojislav M,(broj koautora 20)},
year={2014},
title={Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={32},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Andric Zoran G,...,Zaric Bojan,...,Vukovic Vojislav M,...,(broj koautora 20)},
year={2013},
title={A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={18},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Fennell Dean Anthony,...,Vukovic Vojislav M,...,(broj koautora 17)},
year={2013},
title={GALAXY-2 trial: A randomized phase III study of ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced non-small cell lung adenocarcinoma.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Andric Zoran G,...,Zaric Bojan,Ceric Timur,...,Vukovic Vojislav M,...,(broj koautora 20)},
year={2013},
title={A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Andric Zoran G,Havel L,Di Hariry I,Vukovic Vojislav M,Teofilovici F,Guo W,Mulcahey S,Bradley R,Ceric Timur},
year={2012},
title={Quality of Life Analysis in the Galaxy Trialtm (Nct01348126): a Randomized Phase Iib/Iii Study of Ganetespib (Sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Patients with Stage Iiib Or Iv Nsclc},
journal={ANNALS OF ONCOLOGY},
volume={23},
number={},
pages={436-436},
document_type={Meeting Abstract},
}